(Q54441751)

English

Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.

scientific article published in April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients. (English)

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

author name string

M Schlaak

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

A Bajah

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

T Podewski

3

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

N Kreuzberg

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

W von Bartenwerffer

5

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

E Wardelmann

6

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

S Merkelbach-Bruse

7

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

R Büttner

8

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

C Mauch

9

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

P Kurschat

10

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

language of work or name

0 references

publication date

1 April 2013

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

British Journal of Dermatology

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

168

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

708-716

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

Vemurafenib and BRAF inhibition: a new class of treatment for metastatic melanoma

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and Resistance

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Distinct sets of genetic alterations in melanoma

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Somatic activation of KIT in distinct subtypes of melanoma

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

BRAF targeted therapy changes the treatment paradigm in melanoma

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

NRAS mutation status is an independent prognostic factor in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Toward a molecular classification of melanoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

BRAF somatic mutations in malignant melanoma and melanocytic naevi

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

High frequency of BRAF mutations in nevi

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

MC1R variants increase risk of melanomas harboring BRAF mutations.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

The Validity and Practicality of Sun-Reactive Skin Types I Through VI

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Prognostic value of tumour thickness in cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Determinants of BRAF mutations in primary melanomas

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Improving melanoma classification by integrating genetic and morphologic features

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Clinical correlates of NRAS and BRAF mutations in primary human melanoma

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

KIT amplification and gene mutations in acral/mucosal melanoma in Korea.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Clinical significance of BRAF mutations in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Genetic and morphologic features for melanoma classification

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

BRAF and NRAS Mutations Are Frequent in Nodular Melanoma but Are not Associated with Tumor Cell Proliferation or Patient Survival

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

A Prospective Study of Incident Nonmelanoma Skin Cancer in Heart Transplant Recipients

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12140

21 January 2018

Identifiers

10.1111/BJD.12140

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23528057

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54441751&oldid=975287105"